Stock Market

articles with this tag

IMC Reports Rising Revenues & Eyes Colitis Market

IMC Reports Rising Revenues & Eyes Colitis Market

Immuron Limited (ASX:IMC | NASDAQ:IMRN) is focused on developing and commercialising orally delivered targeted polyclonal antibodies for the treatment of inflammatory mediated and infectious diseases.

READ ARTICLE